Condition
Chronic Lymphocytic Leukaemia (CLL) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Chronic Lymphocytic Leukaemia (CLL) clinical trials that are recruiting, at sites in 3 countries (most in Austria (1), Germany (1), Belarus (1)). By phase: Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
Developing a tool to monitor infections and quality of life in patients with blood cancers and immune issues
This study is testing a new tool that helps people with blood cancers like CLL or multiple myeloma report infections and track their quality of life to see how it can improve their treatment.
-
Combining anti-CD19 CAR T-cells with Lenalidomide in relapsed/refractory CLL/SLL
This trial tests whether giving Lenalidomide together with anti-CD19 CAR T-cell therapy is safe and can help people with relapsed or refractory CLL or SLL who have been on ibrutinib.
Related topics
Quick answers
How many Chronic Lymphocytic Leukaemia (CLL) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Austria (1 trial), Germany (1 trial), Belarus (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.